Dynamic Technology Lab’s Amneal Pharmaceuticals AMRX Stock Holding History

Dynamic Technology Lab’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-29,200	Closed	-$244K	–	917
2025 Q1	$244K	Buy	+29,200	New	+$244K	0.04%	773
2024 Q3	–	Sell	-35,843	Closed	-$227K	–	995
2024 Q2	$227K	Buy	+35,843	New	+$228K	0.03%	760
2023 Q1	–	Sell	-21,976	Closed	-$44K	–	1060
2022 Q4	$44K	Buy	+21,976	New	+$49.3K	﹤0.01%	1026
2021 Q1	–	Sell	-15,244	Closed	-$70K	–	1116
2020 Q4	$70K	Buy	+15,244	New	+$67.6K	0.01%	919
2020 Q1	–	Sell	-19,485	Closed	-$94K	–	998
2019 Q4	$94K	Buy	+19,485	New	+$67.7K	0.02%	895
2019 Q3	–	Sell	-17,110	Closed	-$123K	–	929
2019 Q2	$123K	Sell	17,110 -6,684	-28%	-$68.3K	0.02%	865
2019 Q1	$337K	Buy	+23,794	New	+$314K	0.06%	612

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dynamic Technology Lab's AMRX Position: Q2 2025 in Review

Dynamic Technology Lab sold out of Amneal Pharmaceuticals (AMRX) in Q2 2025, closing a stake of 29,200 shares — an estimated $244K sold.

Dynamic Technology Lab first reported a position in AMRX in Q1 2019 and held it in 7 quarters. The position peaked at $337K in Q1 2019. 241 funds tracked by Wall St. Rank hold AMRX as of Q2 2025.

Dynamic Technology Lab reported no remaining Amneal Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Dynamic Technology Lab sold 29,200 Amneal Pharmaceuticals shares in Q2 2025, an estimated $244K.
Dynamic Technology Lab first reported a position in Amneal Pharmaceuticals in Q1 2019 and held it in 7 quarters.
Dynamic Technology Lab's Amneal Pharmaceuticals position peaked at $337K in Q1 2019.
241 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2025.

Based on Dynamic Technology Lab's 13F filing for Q2 2025, filed 12 Aug 2025.